Home

MLCP GLL Funding LLC

CIK 1722935 · last filed 2018-01-17

MLCP GLL Funding LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for LACQW, was dated Jan 17, 2018. The firm reports its address in New York, NY. 4 SEC filings were submitted jointly with Daniel B. Silvers.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
250 WEST 57TH STREET
SUITE 2223
NEW YORK, NY 10107
Phone
(646) 820-0860
State of Incorporation
DE
Related Filers
Daniel B. Silvers — 4 joint filings, latest 2021-07-01
Hydra LAC, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ensysce Biosciences, Inc. (LACQW) Delisted 1,128,370 $0.90 $1.02M $0 1 2018-01-17
Ensysce Biosciences, Inc. (LACQU) Delisted 1,300,202 — — $0 1 2017-12-05

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-01-17 Ensysce Biosciences, Inc. (LACQW) Delisted Other (J) −515,496 $0 EDGAR
2017-12-05 Ensysce Biosciences, Inc. (LACQU) Delisted Other (J) −1,079,607 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.